ARCHIVES

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: Cancer Panel to Meet Sept. 30 In Boston; House Passes Money Bill, With 41.347 Billion For NCI

August 15, 1986

DCPC Board approves 7 New RFAs, 2 Pas

October 21, 1994

Mayo’s Regional Program – Keys To Success Are Service, Communications

December 9, 1977

NCI Must Limit Grant Payments for Now, Until Congress Approves FY03 Budget

December 6, 2002

NCI Releases 550 Pages of Internal Documents Related To Duke Scandal

January 7, 2011

President’s Budget Would Permit NCI Funding Of Only 23.2% Of Approved Traditional Grants

January 26, 1979